Protalix BioTherapeutics, Inc. (PLX)

ASE – Цена в реальном времени. Валюта: USD

2.65

+0.23 (9.26%)

Рынок открыт: Aug 12, 2026, 12:33 PM EDT

2.40

-0.03 (-1.23%)

Предыдущая сессия: Aug 11, 2026, 7:44 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

05.08.2026

Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026

Company to host conference call and webcast at 8:00 a.m. EDT CARMIEL, Israel, Aug. 5, 2026 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production, and commercialization of innovative therapeutics for rare diseases with significant unmet needs, today announced that it will release its financial results for the quarter ended June 30, 2026 and provide a business update on August 12, 2026.

Видео

No Data

There is no data to display

Protalix BioTherapeutics, Inc. (PLX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Protalix BioTherapeutics, Inc. (PLX)

Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026

Видео

No Data

Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026

Видео

No Data

Search stocks

Protalix BioTherapeutics, Inc. (PLX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Protalix BioTherapeutics, Inc. (PLX)

Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026

Видео

No Data

Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026

Видео

No Data